Close [X]
Companies & Industry »Company News
Unichem Laboratories Ltd - Company News

BSE   08 Dec 16 | 04:01 PM

266.60 4 (1.52%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 506690
Face Value: 2

NSE   08 Dec 16 | 03:53 PM

266.75 3.35 (1.27%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: UNICHEMLAB
Performance
1 Week : Rs 264.75 (0.70%)
1 Month : Rs 271.80 (-1.91%)
1 Year : Rs 270.80 (-1.55%)
change companytradenow

  • 08 Dec 15
    01:19 PM
    Unichem Laboratories has moved higher by 5% to Rs 291, bouncing back 7% from intra-day low on the BSE, after the company announced that it has received final abbreviated new drug application (ANDA) approval from the United States Food and Drug
  • 19 Jan 15
    10:02 AM
    Shares of Unichem Laboratories were down over 5% at Rs 220 after the company reported weak third quarter earnings on the back of higher raw material, employee benefits costs and other expenses.
  • 14 Jul 14
    10:37 AM
    Unichem Laboratories has dipped 4% to Rs 188 after reporting 16% year on year drop in standalone net profit at Rs 30.20 crore for the quarter ended June 30, 2014 (Q1), due higher expenditure and lower other income.
  • 10 Jul 14
    12:49 AM
    Leading domestic drug makers Lupin, Unichem and Matrix Labs (now part of Mylan) have come under the scanner of the European Commission for curbing entry of the low-cost generic version of cardiovascular medicine Perindopril in the European Union (EU).
  • 26 Jul 13
    08:30 AM
    YES Bank - Healthy credit growth, robust fees, stable asset quality; Buy. At 24.3% yoy, advances grew slower than deposits at 29.9% yoy, thereby decreasing the credit-deposit by 334bps yoy, to 73.4%.
  • 19 Jul 13
    04:24 PM
    Drug firm Unichem Laboratories today posted 8.90% rise in net profit at Rs 36.09 crore for the first quarter ended June 30, 2013.   The company had posted a net profit of Rs 33.14 crore during the same period of previous fiscal.
  • 29 Nov 12
    03:34 PM
    Unichem Laboratories Ltd today said it has received American health regulator's approval to market Tizanidine tablets, a drug used to relieve muscle pain, in the US market.
  • 07 Apr 11
    02:45 PM
    Unichem Laboratories today said it has received approval from the US health regulator to market Divalproex Sodium Delayed Release tablets, indicated for seizure disorders, in the American market.
    11:20 AM
    Unichem Laboratories has rallied 7% to Rs 208 after the company said it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Divalproex Sodium Delayed Release Tablets.
  • 23 Sep 10
    01:18 PM
    Unichem Labs has spurted after being granted a certificate of suitability to European Pharmacopeia (CEP) by European Directorate for the Quality of Mechcines and Healthcare (EDQM) for Alfuzosin Hydrochloride.
    12:47 PM
    Unichem Laboratories Ltd, a leading pharmaceutical company in India, has been granted certificate of suitability to European Pharmacopeia (CEP) by European Directorate for the Quality of Mechcines and Healthcare (EDQM) for Alfuzosin Hydrochloride.
1|2|Next
Widgets Magazine

Sensex

Company Price Gain (%)
Tata Steel431.554.62
Tata Motors461.303.60
Adani Ports286.253.30
Bajaj Auto2,776.502.77
Hero Motocorp3,308.952.53
Widgets Magazine

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine